Back
Supreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech
This judgment is a part of the following collection(s): 2023 WIPO Intellectual Property Judges ForumDate of JudgmentMay 25, 2023Issuing AuthoritySupreme People’s Court of the People’s Republic of ChinaLevel of the Issuing AuthorityFinal InstanceType of ProcedureJudicial (Civil)Subject MatterCompetition, Patents (Inventions)Plaintiff/AppellantYangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd; Yangtze River Pharmaceutical Group Co., Ltd.Defendant/RespondentHefei Industrial Pharmaceutical Institute Co., Ltd; Hefei Enrite Pharmaceutical Co., Ltd.Keywords
Patent,
Abuse of dominant market position,
Restricting dealing,
Unfairly high price
Judgment/DecisionEnglishSupreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTMLSummaryEnglishSupreme People’s Court of China [2023]: Yangtze River Pharmaceutical Group v HIPI Pharma Tech HTMLWIPO Lex No.WIPOLEX016-j